Ishita Drugs And IndustriesBOM:524400 +2.99%73 Operating Margin % is 2.53% as of Mar. 2026, which is 49% below its 10-year median of 4.96. GuruFocus rates BOM:524400 with a GF Score™ of 73/100 and a GF Value™ of ₹78.01 (Fairly Valued). The stock has 5 warning signs investors should review. Among 952 Drug Manufacturers companies, Ishita Drugs And Industries ranks worse than 59.03% on this metric.
Ishita Drugs And Industries Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -3.9%.
The historical rank and industry rank for Ishita Drugs And Industries's Operating Margin % or its related term are showing as below:
BOM:524400'
s Operating Margin % Range Over the Past 10 Years
Min: 3.78 Med: 4.96 Max: 6.82
Current: 4.54
BOM:524400's Operating Margin % is ranked worse than 59.03% of 952
companies
in the Drug Manufacturers industry
Industry Median: 7.58
vs BOM:524400: 4.54
Ishita Drugs And Industries (BOM:524400) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Ishita Drugs And Industries Operating Margin % Related Terms
Ishita Drugs And Industries Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ishita Drugs And Industries Operating Margin % Chart
BOM:524400 vs ZTS, UTHR: Operating Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ishita Drugs And Industries's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ishita Drugs And Industries Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ishita Drugs And Industries's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Ishita Drugs And Industries's Operating Margin % falls into.
Ishita Drugs And Industries Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Ishita Drugs And Industries's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ishita Drugs And Industries (BOM:524400) has a Operating Margin % of 2.53% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Ishita Drugs And Industries and its competitors. This is 49% below median its historical median of 4.96. Over the past decade, Ishita Drugs And Industries' Operating Margin % has ranged from 3.78 to 6.82. According to the industry distribution chart, Ishita Drugs And Industries ranks #562 out of 952 companies in the Drug Manufacturers industry, placing it in the top 59%.
Is Ishita Drugs And Industries' Operating Margin % too high?
Ishita Drugs And Industries' current Operating Margin % of 2.53% is 49% below median its 10-year median of 4.96. Over the past 10 years, this metric has ranged from a low of 3.78 to a high of 6.82. The Drug Manufacturers industry median Operating Margin % is 7.58. Ishita Drugs And Industries' value of 2.53% is 66.6% below this industry median. Based on the distribution chart, Ishita Drugs And Industries ranks #562 out of 952 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Ishita Drugs And Industries has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ishita Drugs And Industries' Operating Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ishita Drugs And Industries ranks #562 out of 952 companies for Operating Margin %. This places Ishita Drugs And Industries in the lower half of its industry. The industry median Operating Margin % is 7.58. Ishita Drugs And Industries' value of 2.53% is 66.6% below this benchmark. Historically, Ishita Drugs And Industries' own Operating Margin % has ranged from 3.78 to 6.82 over the past decade. While the company's 10-year median is 4.96 vs. the industry median of 7.58, Ishita Drugs And Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.58, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ishita Drugs And Industries's current Operating Margin % of 2.53% is 66.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Ishita Drugs And Industries and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ishita Drugs And Industries's current Operating Margin % is 2.53%, which is 49% below median its own 10-year median of 4.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ishita Drugs And Industries stock overvalued right now?
Based on GuruFocus' analysis, Ishita Drugs And Industries (BOM:524400) is currently considered Fairly Valued. The stock's GF Value™ is ₹78.01, compared to a current price of ₹76.13 — trading 2.4% below its estimated fair value. The current Operating Margin % is 2.53%, which is 49% below median its 10-year median of 4.96 and 66.6% below the Drug Manufacturers industry median of 7.58. Ishita Drugs And Industries' overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Ishita Drugs And Industries (BOM:524400), the current Operating Margin % is 2.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ishita Drugs And Industries (BOM:524400) Overvalued in 2026?
Based on GuruFocus' analysis, Ishita Drugs And Industries stock appears to be undervalued.
The current stock price of ₹76.13 is trading 2.4% below its estimated GF Value™ of ₹78.01.
GuruFocus considers Ishita Drugs And Industries to be Fairly Valued.
Key valuation signals for BOM:524400:
Operating Margin %: 2.53% (49% below median its 10-year median of 4.96)
GF Value™: ₹78.01 vs. price of ₹76.13 (2.4% below fair value)
Industry Position: 66.6% below the Drug Manufacturers median (#562 of 952)
No single metric tells the full story. See the BOM:524400 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ishita Drugs And Industries Ltd is engaged in the business of manufacturing various APIs and drug intermediates. The company supplies its products to various pharmaceutical companies and is also being exported to various countries across the world. The company has three manufacturing facilities located in the state of Gujarat, two for APIs and drug intermediates at Ahmedabad and Surendranagar, and one for finished pharmaceutical formulations at Mehsana.
73GF Score
Get the complete analysis for BOM:524400
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524400 has been successfully added to your 
